FASLG and nonpapillary renal cell carcinoma: In addition, we did not observe differences in the frequency and amounts of expression of molecules involved in the cytotoxic function of NK cells via the death receptor pathway, such as FasL and TRAIL, in both subsets of PBNK from ccRCC patients compared to HD (not shown).